These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

602 related items for PubMed ID: 26896955

  • 21. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
    Zięba S, Kowalik A, Zalewski K, Rusetska N, Goryca K, Piaścik A, Misiek M, Bakuła-Zalewska E, Kopczyński J, Kowalski K, Radziszewski J, Bidziński M, Góźdź S, Kowalewska M.
    Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
    [Abstract] [Full Text] [Related]

  • 22. Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
    Eder T, Hess AK, Konschak R, Stromberger C, Jöhrens K, Fleischer V, Hummel M, Balermpas P, von der Grün J, Linge A, Lohaus F, Krause M, Baumann M, Stuschke M, Zips D, Grosu AL, Abdollahi A, Debus J, Belka C, Pigorsch S, Combs SE, Budach V, Tinhofer I, DKTK-ROG.
    Eur J Cancer; 2019 Jul; 116():67-76. PubMed ID: 31173964
    [Abstract] [Full Text] [Related]

  • 23. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.
    Koch WM, Brennan JA, Zahurak M, Goodman SN, Westra WH, Schwab D, Yoo GH, Lee DJ, Forastiere AA, Sidransky D.
    J Natl Cancer Inst; 1996 Nov 06; 88(21):1580-6. PubMed ID: 8901856
    [Abstract] [Full Text] [Related]

  • 24. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.
    Hafkamp HC, Speel EJ, Haesevoets A, Bot FJ, Dinjens WN, Ramaekers FC, Hopman AH, Manni JJ.
    Int J Cancer; 2003 Nov 10; 107(3):394-400. PubMed ID: 14506739
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY, Zuo Z, Keck MK, Khattri A, Pedamallu CS, Stricker T, Brown C, Pugh TJ, Stojanov P, Cho J, Lawrence MS, Getz G, Brägelmann J, DeBoer R, Weichselbaum RR, Langerman A, Portugal L, Blair E, Stenson K, Lingen MW, Cohen EE, Vokes EE, White KP, Hammerman PS.
    Clin Cancer Res; 2015 Feb 01; 21(3):632-41. PubMed ID: 25056374
    [Abstract] [Full Text] [Related]

  • 27. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G, Karaca Y, Lechien JR, Kindt N, Decaestecker C, Remmelink M, Larsimont D, Andry G, Hassid S, Rodriguez A, Khalife M, Journe F, Saussez S.
    J Cancer Res Clin Oncol; 2016 Oct 01; 142(10):2185-96. PubMed ID: 27370781
    [Abstract] [Full Text] [Related]

  • 28. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
    Xing D, Fadare O.
    Semin Diagn Pathol; 2021 Jan 01; 38(1):50-61. PubMed ID: 33032902
    [Abstract] [Full Text] [Related]

  • 29. Translational Research: A Future Strategy for Managing Squamous Cell Carcinoma of the Head and Neck?
    Caponigro F, Ionna F, Scarpati GDV, Longo F, Addeo R, Manzo R, Muto P, Pisconti S, Leopaldi L, Perri F.
    Anticancer Agents Med Chem; 2018 Jan 01; 18(9):1220-1227. PubMed ID: 29637868
    [Abstract] [Full Text] [Related]

  • 30. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ, Urban D, Angel C, Corry J, Lyons B, Vallance N, Kleid S, Iseli TA, Solomon B, Rischin D.
    Br J Cancer; 2015 Mar 17; 112(6):1098-104. PubMed ID: 25688737
    [Abstract] [Full Text] [Related]

  • 31. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Linge A, Lohaus F, Löck S, Nowak A, Gudziol V, Valentini C, von Neubeck C, Jütz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Krause M, Baumann M, DKTK-ROG.
    Radiother Oncol; 2016 Dec 17; 121(3):364-373. PubMed ID: 27913065
    [Abstract] [Full Text] [Related]

  • 32. Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.
    Sewell A, Brown B, Biktasova A, Mills GB, Lu Y, Tyson DR, Issaeva N, Yarbrough WG.
    Clin Cancer Res; 2014 May 01; 20(9):2300-11. PubMed ID: 24599934
    [Abstract] [Full Text] [Related]

  • 33. Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
    Beck TN, Smith CH, Flieder DB, Galloway TJ, Ridge JA, Golemis EA, Mehra R.
    Head Neck; 2017 Mar 01; 39(3):E34-E39. PubMed ID: 27859938
    [Abstract] [Full Text] [Related]

  • 34. Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer.
    Deneka AY, Baca Y, Serebriiskii IG, Nicolas E, Parker MI, Nguyen TT, Xiu J, Korn WM, Demeure MJ, Wise-Draper T, Sukari A, Burtness B, Golemis EA.
    Clin Cancer Res; 2022 May 02; 28(9):1925-1937. PubMed ID: 35491653
    [Abstract] [Full Text] [Related]

  • 35. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.
    Tanvetyanon T, Padhya T, McCaffrey J, Kish JA, Deconti RC, Trotti A, Rao NG.
    Head Neck; 2015 Jun 02; 37(6):840-5. PubMed ID: 24623654
    [Abstract] [Full Text] [Related]

  • 36. p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck.
    Scholes AG, Liloglou T, Snijders PJ, Hart CA, Jones AS, Woolgar JA, Vaughan ED, Walboomers JM, Field JK.
    Int J Cancer; 1997 May 29; 71(5):796-9. PubMed ID: 9180148
    [Abstract] [Full Text] [Related]

  • 37. Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population.
    Maruyama H, Yasui T, Ishikawa-Fujiwara T, Morii E, Yamamoto Y, Yoshii T, Takenaka Y, Nakahara S, Todo T, Hongyo T, Inohara H.
    Cancer Sci; 2014 Apr 29; 105(4):409-17. PubMed ID: 24521534
    [Abstract] [Full Text] [Related]

  • 38. Molecular profiling of head and neck squamous cell carcinoma.
    Feldman R, Gatalica Z, Knezetic J, Reddy S, Nathan CA, Javadi N, Teknos T.
    Head Neck; 2016 Apr 29; 38 Suppl 1(Suppl 1):E1625-38. PubMed ID: 26614708
    [Abstract] [Full Text] [Related]

  • 39. Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation.
    Zhang D, Zhang W, Liu W, Mao Y, Fu Z, Liu J, Huang W, Zhang Z, An D, Li B.
    Radiother Oncol; 2017 Jul 29; 124(1):155-160. PubMed ID: 28647401
    [Abstract] [Full Text] [Related]

  • 40. Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?
    Ou D, Levy A, Blanchard P, Nguyen F, Garberis I, Casiraghi O, Scoazec JY, Janot F, Temam S, Deutsch E, Tao Y.
    Oral Oncol; 2016 Aug 29; 59():50-57. PubMed ID: 27424182
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.